Innovations in medical research lead to novel medical devices and pharmaceuticals that ultimately must be critically evaluated before they can be considered standard of care. Mitscherlich Consulting, specializing in reimbursement issues, offers the following services to aid in facilitating this process:
Health Technology Assessment (HTA)
assistance defining what is required for successful product adoption
evidence evaluation and identification of existing evidence gaps
design and implementation of clinical studies
commissioning research
minimization of processes that demonstrate and validate clinical value
Reimbursement Solutions Strategy
development for successful reimbursement positioning
